Tags

Type your tag names separated by a space and hit enter

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Vaccine. 2005 Jan 26; 23(10):1294-300.V

Abstract

Outer membrane protein P4, together with P6, is highly conserved among all typeable and nontypeable strains of Haemophilus influenzae (H. influenzae). Thus, the protein is an attractive antigen for the inclusion in a vaccine against nontypeable H. influenzae (NTHi). However, the ability of P4 to induce antibodies protective against NTHi infections is still controversial. In this study, we investigated the specific mucosal immune responses against NTHi induced by intranasal immunization with the lipidated form of recombinant P4 protein (rP4) and non-fatty acylated recombinant P6 protein (rP6) with or without cholera toxin (CT) in BALB/c mice model. Intranasal immunization with either rP4+CT, a mixture of rP4 and rP6+CT, or rP4 and rP6 without CT elicited anti-rP4 specific IgG antibody in serum of mice. Intranasal immunization with either rP4+CT or a mixture of rP4, rP6+CT elicited anti-rP4 specific IgA antibody in nasopharyngeal washing (NPW), while intranasal immunization with rP4 and rP6 without CT did not induced anti-rP4 specific IgA antibody responses in NPWs. Sera from mice intranasally immunized with rP4+CT and a mixture of rP4, rP6+CT also showed bactericidal activity. Significant clearance of NTHi in nasopharynx was seen 3 days after the inoculation of live NTHi in mice intranasally immunized with rP4+CT. The current findings suggested that P4 would be a useful antigen as the component of the vaccine to induce protective immune responses against NTHi. The use of an intranasal vaccine composed of the different surface protein antigens is an attractive strategy for the development of a vaccine against NTHi.

Authors+Show Affiliations

Department of Otolaryngology-Head and Neck Surgery, Wakayama Medical University, Kimiidera 811-1, Wakayama-shi 641-0032, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15652672

Citation

Hotomi, Muneki, et al. "A Recombinant P4 Protein of Haemophilus Influenzae Induces Specific Immune Responses Biologically Active Against Nasopharyngeal Colonization in Mice After Intranasal Immunization." Vaccine, vol. 23, no. 10, 2005, pp. 1294-300.
Hotomi M, Ikeda Y, Suzumoto M, et al. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine. 2005;23(10):1294-300.
Hotomi, M., Ikeda, Y., Suzumoto, M., Yamauchi, K., Green, B. A., Zlotnick, G., Billal, D. S., Shimada, J., Fujihara, K., & Yamanaka, N. (2005). A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine, 23(10), 1294-300.
Hotomi M, et al. A Recombinant P4 Protein of Haemophilus Influenzae Induces Specific Immune Responses Biologically Active Against Nasopharyngeal Colonization in Mice After Intranasal Immunization. Vaccine. 2005 Jan 26;23(10):1294-300. PubMed PMID: 15652672.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. AU - Hotomi,Muneki, AU - Ikeda,Yorihiko, AU - Suzumoto,Masaki, AU - Yamauchi,Kazuma, AU - Green,Bruce A, AU - Zlotnick,Gary, AU - Billal,Dewan S, AU - Shimada,Jun, AU - Fujihara,Keiji, AU - Yamanaka,Noboru, PY - 2004/01/05/received PY - 2004/07/26/revised PY - 2004/08/06/accepted PY - 2005/1/18/pubmed PY - 2005/4/19/medline PY - 2005/1/18/entrez SP - 1294 EP - 300 JF - Vaccine JO - Vaccine VL - 23 IS - 10 N2 - Outer membrane protein P4, together with P6, is highly conserved among all typeable and nontypeable strains of Haemophilus influenzae (H. influenzae). Thus, the protein is an attractive antigen for the inclusion in a vaccine against nontypeable H. influenzae (NTHi). However, the ability of P4 to induce antibodies protective against NTHi infections is still controversial. In this study, we investigated the specific mucosal immune responses against NTHi induced by intranasal immunization with the lipidated form of recombinant P4 protein (rP4) and non-fatty acylated recombinant P6 protein (rP6) with or without cholera toxin (CT) in BALB/c mice model. Intranasal immunization with either rP4+CT, a mixture of rP4 and rP6+CT, or rP4 and rP6 without CT elicited anti-rP4 specific IgG antibody in serum of mice. Intranasal immunization with either rP4+CT or a mixture of rP4, rP6+CT elicited anti-rP4 specific IgA antibody in nasopharyngeal washing (NPW), while intranasal immunization with rP4 and rP6 without CT did not induced anti-rP4 specific IgA antibody responses in NPWs. Sera from mice intranasally immunized with rP4+CT and a mixture of rP4, rP6+CT also showed bactericidal activity. Significant clearance of NTHi in nasopharynx was seen 3 days after the inoculation of live NTHi in mice intranasally immunized with rP4+CT. The current findings suggested that P4 would be a useful antigen as the component of the vaccine to induce protective immune responses against NTHi. The use of an intranasal vaccine composed of the different surface protein antigens is an attractive strategy for the development of a vaccine against NTHi. SN - 0264-410X UR - https://www.unboundmedicine.com/medline/citation/15652672/A_recombinant_P4_protein_of_Haemophilus_influenzae_induces_specific_immune_responses_biologically_active_against_nasopharyngeal_colonization_in_mice_after_intranasal_immunization_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(04)00667-X DB - PRIME DP - Unbound Medicine ER -